nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—DGUOK—telencephalon—epilepsy syndrome	0.00743	0.0983	CbGeAlD
Nelarabine—DGUOK—medulla oblongata—epilepsy syndrome	0.00584	0.0772	CbGeAlD
Nelarabine—DGUOK—midbrain—epilepsy syndrome	0.00534	0.0706	CbGeAlD
Nelarabine—DGUOK—spinal cord—epilepsy syndrome	0.00521	0.0689	CbGeAlD
Nelarabine—Abacavir—ADK—epilepsy syndrome	0.0047	0.284	CrCbGaD
Nelarabine—DGUOK—head—epilepsy syndrome	0.00463	0.0612	CbGeAlD
Nelarabine—DGUOK—nervous system—epilepsy syndrome	0.00439	0.058	CbGeAlD
Nelarabine—DGUOK—central nervous system—epilepsy syndrome	0.00422	0.0559	CbGeAlD
Nelarabine—DGUOK—cerebellum—epilepsy syndrome	0.00413	0.0546	CbGeAlD
Nelarabine—DGUOK—brain—epilepsy syndrome	0.00335	0.0444	CbGeAlD
Nelarabine—DCK—Niclosamide—Clonazepam—epilepsy syndrome	0.00301	1	CbGdCrCtD
Nelarabine—DCK—telencephalon—epilepsy syndrome	0.00283	0.0374	CbGeAlD
Nelarabine—ADA—head—epilepsy syndrome	0.00265	0.035	CbGeAlD
Nelarabine—POLA1—cerebellum—epilepsy syndrome	0.00255	0.0337	CbGeAlD
Nelarabine—ADA—nervous system—epilepsy syndrome	0.00251	0.0332	CbGeAlD
Nelarabine—ADA—central nervous system—epilepsy syndrome	0.00242	0.032	CbGeAlD
Nelarabine—DCK—medulla oblongata—epilepsy syndrome	0.00222	0.0294	CbGeAlD
Nelarabine—POLA1—brain—epilepsy syndrome	0.00207	0.0274	CbGeAlD
Nelarabine—DCK—midbrain—epilepsy syndrome	0.00203	0.0269	CbGeAlD
Nelarabine—DCK—spinal cord—epilepsy syndrome	0.00198	0.0262	CbGeAlD
Nelarabine—ADA—brain—epilepsy syndrome	0.00192	0.0254	CbGeAlD
Nelarabine—Adenosine triphosphate—AFG3L2—epilepsy syndrome	0.00187	0.113	CrCbGaD
Nelarabine—Vidarabine—ADK—epilepsy syndrome	0.00183	0.11	CrCbGaD
Nelarabine—Ribavirin—ADK—epilepsy syndrome	0.0018	0.109	CrCbGaD
Nelarabine—DCK—head—epilepsy syndrome	0.00176	0.0233	CbGeAlD
Nelarabine—DCK—nervous system—epilepsy syndrome	0.00167	0.0221	CbGeAlD
Nelarabine—DCK—central nervous system—epilepsy syndrome	0.00161	0.0213	CbGeAlD
Nelarabine—DCK—cerebellum—epilepsy syndrome	0.00157	0.0208	CbGeAlD
Nelarabine—Adenosine—ADK—epilepsy syndrome	0.00146	0.0882	CrCbGaD
Nelarabine—Cytarabine—NT5E—epilepsy syndrome	0.00137	0.0831	CrCbGaD
Nelarabine—DCK—brain—epilepsy syndrome	0.00128	0.0169	CbGeAlD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—BDKRB2—epilepsy syndrome	0.00116	0.00371	CbGpPWpGaD
Nelarabine—DCK—Purine metabolism—CAT—epilepsy syndrome	0.00114	0.00365	CbGpPWpGaD
Nelarabine—ADA—Purine metabolism—GPX1—epilepsy syndrome	0.00112	0.00357	CbGpPWpGaD
Nelarabine—POLA1—Extension of Telomeres—APEX1—epilepsy syndrome	0.00106	0.00341	CbGpPWpGaD
Nelarabine—Adenosine monophosphate—ADK—epilepsy syndrome	0.00105	0.0637	CrCbGaD
Nelarabine—DGUOK—Metabolism—CA13—epilepsy syndrome	0.00103	0.0033	CbGpPWpGaD
Nelarabine—DCK—Purine metabolism—GPX1—epilepsy syndrome	0.00103	0.0033	CbGpPWpGaD
Nelarabine—POLA1—DNA strand elongation—APEX1—epilepsy syndrome	0.000984	0.00315	CbGpPWpGaD
Nelarabine—Adenosine triphosphate—ADK—epilepsy syndrome	0.000915	0.0553	CrCbGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—VDR—epilepsy syndrome	0.000903	0.00289	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—HES1—epilepsy syndrome	0.000884	0.00283	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—NTRK3—epilepsy syndrome	0.000863	0.00276	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of TAp63 isoforms—VDR—epilepsy syndrome	0.000808	0.00259	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—FAR1—epilepsy syndrome	0.000782	0.0025	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ADK—epilepsy syndrome	0.000782	0.0025	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—L2HGDH—epilepsy syndrome	0.000782	0.0025	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GLUD1—epilepsy syndrome	0.000782	0.0025	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CERS1—epilepsy syndrome	0.000782	0.0025	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PDXK—epilepsy syndrome	0.000782	0.0025	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NHLRC1—epilepsy syndrome	0.000715	0.00229	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PNPO—epilepsy syndrome	0.000715	0.00229	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—EPM2A—epilepsy syndrome	0.000715	0.00229	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GAMT—epilepsy syndrome	0.000715	0.00229	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—NPY2R—epilepsy syndrome	0.000704	0.00225	CbGpPWpGaD
Nelarabine—ADA—Validated transcriptional targets of deltaNp63 isoforms—ATM—epilepsy syndrome	0.000696	0.00223	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—QDPR—epilepsy syndrome	0.000665	0.00213	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CA4—epilepsy syndrome	0.000665	0.00213	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—COX3—epilepsy syndrome	0.000625	0.002	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—UBE3A—epilepsy syndrome	0.000624	0.002	CbGpPWpGaD
Nelarabine—ADA—Nucleotide metabolism—CAT—epilepsy syndrome	0.00062	0.00199	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—NTF3—epilepsy syndrome	0.000607	0.00194	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—SIRT1—epilepsy syndrome	0.000605	0.00194	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—CHRM1—epilepsy syndrome	0.000598	0.00192	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—KCNB1—epilepsy syndrome	0.000592	0.0019	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SLCO1A2—epilepsy syndrome	0.000592	0.0019	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PFKL—epilepsy syndrome	0.000592	0.0019	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CACNA2D2—epilepsy syndrome	0.000592	0.0019	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SLC6A8—epilepsy syndrome	0.000592	0.0019	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—KCNMA1—epilepsy syndrome	0.000583	0.00187	CbGpPWpGaD
Nelarabine—DCK—Nucleotide metabolism—CAT—epilepsy syndrome	0.000572	0.00183	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CAPN1—epilepsy syndrome	0.000571	0.00183	CbGpPWpGaD
Nelarabine—ADA—Nucleotide metabolism—GPX1—epilepsy syndrome	0.000561	0.0018	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—HES1—epilepsy syndrome	0.000555	0.00178	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ATIC—epilepsy syndrome	0.000542	0.00173	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NEU1—epilepsy syndrome	0.000542	0.00173	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—UPB1—epilepsy syndrome	0.000542	0.00173	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—JUND—epilepsy syndrome	0.000523	0.00167	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—HSD17B4—epilepsy syndrome	0.000521	0.00167	CbGpPWpGaD
Nelarabine—DCK—Nucleotide metabolism—GPX1—epilepsy syndrome	0.000518	0.00166	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPP1R3C—epilepsy syndrome	0.000504	0.00161	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GBE1—epilepsy syndrome	0.000504	0.00161	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—MAPK10—epilepsy syndrome	0.0005	0.0016	CbGpPWpGaD
Nelarabine—POLA1—Telomere Maintenance—APEX1—epilepsy syndrome	0.000482	0.00154	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ASAH1—epilepsy syndrome	0.000474	0.00152	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—CHRNB2—epilepsy syndrome	0.000469	0.0015	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—STXBP1—epilepsy syndrome	0.000461	0.00148	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALAD—epilepsy syndrome	0.000449	0.00144	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NT5E—epilepsy syndrome	0.000449	0.00144	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—SIRT1—epilepsy syndrome	0.000435	0.00139	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ALDH7A1—epilepsy syndrome	0.000428	0.00137	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CACNA1A—epilepsy syndrome	0.000428	0.00137	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—CRH—epilepsy syndrome	0.000426	0.00137	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ST3GAL3—epilepsy syndrome	0.000419	0.00134	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ADSL—epilepsy syndrome	0.000411	0.00131	CbGpPWpGaD
Nelarabine—POLA1—Synthesis of DNA—APEX1—epilepsy syndrome	0.000408	0.00131	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GLUL—epilepsy syndrome	0.000403	0.00129	CbGpPWpGaD
Nelarabine—POLA1—Chromosome Maintenance—APEX1—epilepsy syndrome	0.000402	0.00129	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—SLC6A4—epilepsy syndrome	0.000396	0.00127	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CACNA1D—epilepsy syndrome	0.000395	0.00127	CbGpPWpGaD
Nelarabine—POLA1—Telomere Maintenance—H2AFX—epilepsy syndrome	0.000386	0.00123	CbGpPWpGaD
Nelarabine—Adenosine triphosphate—AKT1—epilepsy syndrome	0.000386	0.0233	CrCbGaD
Nelarabine—POLA1—DNA Replication—APEX1—epilepsy syndrome	0.000383	0.00123	CbGpPWpGaD
Nelarabine—Adenosine monophosphate—SRC—epilepsy syndrome	0.00038	0.023	CrCbGaD
Nelarabine—DGUOK—Metabolism—TXNRD1—epilepsy syndrome	0.00037	0.00118	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EIF2AK2—epilepsy syndrome	0.000368	0.00118	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUND—epilepsy syndrome	0.000368	0.00118	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AQP1—epilepsy syndrome	0.000359	0.00115	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—TH—epilepsy syndrome	0.000353	0.00113	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—PLAU—epilepsy syndrome	0.000348	0.00112	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—HTR7—epilepsy syndrome	0.000347	0.00111	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CA13—epilepsy syndrome	0.000342	0.0011	CbGpPWpGaD
Nelarabine—ADA—p73 transcription factor network—RELA—epilepsy syndrome	0.000336	0.00108	CbGpPWpGaD
Nelarabine—POLA1—S Phase—APEX1—epilepsy syndrome	0.000335	0.00107	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PAFAH1B1—epilepsy syndrome	0.000334	0.00107	CbGpPWpGaD
Nelarabine—Clofarabine—ABCG2—epilepsy syndrome	0.000331	0.02	CrCbGaD
Nelarabine—POLA1—E2F transcription factor network—ATM—epilepsy syndrome	0.00033	0.00106	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—BCL2—epilepsy syndrome	0.000328	0.00105	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CHRM3—epilepsy syndrome	0.000325	0.00104	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—KCNJ11—epilepsy syndrome	0.000325	0.00104	CbGpPWpGaD
Nelarabine—POLA1—Chromosome Maintenance—H2AFX—epilepsy syndrome	0.000321	0.00103	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CA13—epilepsy syndrome	0.000316	0.00101	CbGpPWpGaD
Nelarabine—ADA—C-MYB transcription factor network—PTGS2—epilepsy syndrome	0.000311	0.000997	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—AVP—epilepsy syndrome	0.000292	0.000936	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—SIRT1—epilepsy syndrome	0.000287	0.000918	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ABCG2—epilepsy syndrome	0.000265	0.000847	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CERS1—epilepsy syndrome	0.000259	0.000831	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GLUD1—epilepsy syndrome	0.000259	0.000831	CbGpPWpGaD
Nelarabine—ADA—Metabolism—L2HGDH—epilepsy syndrome	0.000259	0.000831	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PDXK—epilepsy syndrome	0.000259	0.000831	CbGpPWpGaD
Nelarabine—ADA—Metabolism—FAR1—epilepsy syndrome	0.000259	0.000831	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ADK—epilepsy syndrome	0.000259	0.000831	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP2C19—epilepsy syndrome	0.000258	0.000826	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP11A1—epilepsy syndrome	0.000256	0.000821	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUNB—epilepsy syndrome	0.00025	0.000802	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PAFAH1B1—epilepsy syndrome	0.00025	0.000801	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PDXK—epilepsy syndrome	0.000239	0.000767	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CERS1—epilepsy syndrome	0.000239	0.000767	CbGpPWpGaD
Nelarabine—DCK—Metabolism—FAR1—epilepsy syndrome	0.000239	0.000767	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GLUD1—epilepsy syndrome	0.000239	0.000767	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ADK—epilepsy syndrome	0.000239	0.000767	CbGpPWpGaD
Nelarabine—DCK—Metabolism—L2HGDH—epilepsy syndrome	0.000239	0.000767	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GAMT—epilepsy syndrome	0.000237	0.00076	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PNPO—epilepsy syndrome	0.000237	0.00076	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NHLRC1—epilepsy syndrome	0.000237	0.00076	CbGpPWpGaD
Nelarabine—ADA—Metabolism—EPM2A—epilepsy syndrome	0.000237	0.00076	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP2D6—epilepsy syndrome	0.000231	0.000741	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PAFAH1B1—epilepsy syndrome	0.000224	0.000716	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CA4—epilepsy syndrome	0.000221	0.000706	CbGpPWpGaD
Nelarabine—ADA—Metabolism—QDPR—epilepsy syndrome	0.000221	0.000706	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—ADRA2A—epilepsy syndrome	0.00022	0.000705	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—BCHE—epilepsy syndrome	0.000219	0.000702	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NHLRC1—epilepsy syndrome	0.000219	0.000701	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GAMT—epilepsy syndrome	0.000219	0.000701	CbGpPWpGaD
Nelarabine—DCK—Metabolism—EPM2A—epilepsy syndrome	0.000219	0.000701	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PNPO—epilepsy syndrome	0.000219	0.000701	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—NOS2—epilepsy syndrome	0.000211	0.000674	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SLC2A1—epilepsy syndrome	0.000209	0.00067	CbGpPWpGaD
Nelarabine—ADA—Metabolism—COX3—epilepsy syndrome	0.000207	0.000664	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PLCB1—epilepsy syndrome	0.000207	0.000662	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—TH—epilepsy syndrome	0.000206	0.00066	CbGpPWpGaD
Nelarabine—DCK—Metabolism—QDPR—epilepsy syndrome	0.000204	0.000652	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CA4—epilepsy syndrome	0.000204	0.000652	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	0.000202	0.000648	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	0.000202	0.000646	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—epilepsy syndrome	0.000199	0.000638	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLCO1A2—epilepsy syndrome	0.000197	0.00063	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC6A8—epilepsy syndrome	0.000197	0.00063	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CACNA2D2—epilepsy syndrome	0.000197	0.00063	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PFKL—epilepsy syndrome	0.000197	0.00063	CbGpPWpGaD
Nelarabine—ADA—Metabolism—KCNB1—epilepsy syndrome	0.000197	0.00063	CbGpPWpGaD
Nelarabine—DCK—Metabolism—COX3—epilepsy syndrome	0.000191	0.000613	CbGpPWpGaD
Nelarabine—Cladribine—ABCG2—epilepsy syndrome	0.00019	0.0115	CrCbGaD
Nelarabine—Adenosine triphosphate—ABCC2—epilepsy syndrome	0.000183	0.0111	CrCbGaD
Nelarabine—DCK—Metabolism—PFKL—epilepsy syndrome	0.000181	0.000581	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CACNA2D2—epilepsy syndrome	0.000181	0.000581	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLCO1A2—epilepsy syndrome	0.000181	0.000581	CbGpPWpGaD
Nelarabine—DCK—Metabolism—KCNB1—epilepsy syndrome	0.000181	0.000581	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC6A8—epilepsy syndrome	0.000181	0.000581	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ATIC—epilepsy syndrome	0.00018	0.000576	CbGpPWpGaD
Nelarabine—ADA—Metabolism—UPB1—epilepsy syndrome	0.00018	0.000576	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NEU1—epilepsy syndrome	0.00018	0.000576	CbGpPWpGaD
Nelarabine—Cardiac disorder—Gabapentin—epilepsy syndrome	0.000178	0.0003	CcSEcCtD
Nelarabine—Asthenia—Diazepam—epilepsy syndrome	0.000177	0.000298	CcSEcCtD
Nelarabine—Body temperature increased—Phenytoin—epilepsy syndrome	0.000177	0.000298	CcSEcCtD
Nelarabine—Constipation—Lamotrigine—epilepsy syndrome	0.000176	0.000298	CcSEcCtD
Nelarabine—Pain—Lamotrigine—epilepsy syndrome	0.000176	0.000298	CcSEcCtD
Nelarabine—Nausea—Acetazolamide—epilepsy syndrome	0.000176	0.000297	CcSEcCtD
Nelarabine—Dizziness—Levetiracetam—epilepsy syndrome	0.000176	0.000297	CcSEcCtD
Nelarabine—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000176	0.000297	CcSEcCtD
Nelarabine—Abdominal pain—Oxcarbazepine—epilepsy syndrome	0.000176	0.000297	CcSEcCtD
Nelarabine—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000176	0.000297	CcSEcCtD
Nelarabine—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000176	0.000297	CcSEcCtD
Nelarabine—Neuropathy peripheral—Topiramate—epilepsy syndrome	0.000176	0.000297	CcSEcCtD
Nelarabine—Back pain—Pregabalin—epilepsy syndrome	0.000176	0.000296	CcSEcCtD
Nelarabine—Cough—Valproic Acid—epilepsy syndrome	0.000175	0.000296	CcSEcCtD
Nelarabine—Vomiting—Propofol—epilepsy syndrome	0.000175	0.000296	CcSEcCtD
Nelarabine—Stomatitis—Topiramate—epilepsy syndrome	0.000175	0.000295	CcSEcCtD
Nelarabine—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	0.000175	0.000295	CcSEcCtD
Nelarabine—ADA—Metabolism—HSD17B4—epilepsy syndrome	0.000173	0.000554	CbGpPWpGaD
Nelarabine—Headache—Propofol—epilepsy syndrome	0.000173	0.000291	CcSEcCtD
Nelarabine—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000172	0.000291	CcSEcCtD
Nelarabine—DGUOK—Metabolism—HMOX1—epilepsy syndrome	0.000172	0.000551	CbGpPWpGaD
Nelarabine—Chills—Gabapentin—epilepsy syndrome	0.000172	0.00029	CcSEcCtD
Nelarabine—Vomiting—Midazolam—epilepsy syndrome	0.000171	0.000289	CcSEcCtD
Nelarabine—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000171	0.000289	CcSEcCtD
Nelarabine—Asthenia—Felbamate—epilepsy syndrome	0.000171	0.000289	CcSEcCtD
Nelarabine—Vision blurred—Pregabalin—epilepsy syndrome	0.000171	0.000289	CcSEcCtD
Nelarabine—Arthralgia—Valproic Acid—epilepsy syndrome	0.000171	0.000289	CcSEcCtD
Nelarabine—Chest pain—Valproic Acid—epilepsy syndrome	0.000171	0.000289	CcSEcCtD
Nelarabine—Myalgia—Valproic Acid—epilepsy syndrome	0.000171	0.000289	CcSEcCtD
Nelarabine—Tremor—Pregabalin—epilepsy syndrome	0.00017	0.000287	CcSEcCtD
Nelarabine—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.00017	0.000287	CcSEcCtD
Nelarabine—Dizziness—Fosphenytoin—epilepsy syndrome	0.00017	0.000287	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CAT—epilepsy syndrome	0.00017	0.000544	CbGpPWpGaD
Nelarabine—Vomiting—Levetiracetam—epilepsy syndrome	0.000169	0.000286	CcSEcCtD
Nelarabine—Epistaxis—Topiramate—epilepsy syndrome	0.000169	0.000285	CcSEcCtD
Nelarabine—Headache—Midazolam—epilepsy syndrome	0.000169	0.000285	CcSEcCtD
Nelarabine—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000169	0.000285	CcSEcCtD
Nelarabine—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000169	0.000285	CcSEcCtD
Nelarabine—Diarrhoea—Diazepam—epilepsy syndrome	0.000169	0.000285	CcSEcCtD
Nelarabine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000169	0.000285	CcSEcCtD
Nelarabine—Sinusitis—Topiramate—epilepsy syndrome	0.000168	0.000284	CcSEcCtD
Nelarabine—Anaemia—Pregabalin—epilepsy syndrome	0.000168	0.000283	CcSEcCtD
Nelarabine—Asthenia—Zonisamide—epilepsy syndrome	0.000168	0.000283	CcSEcCtD
Nelarabine—Mental disorder—Gabapentin—epilepsy syndrome	0.000168	0.000283	CcSEcCtD
Nelarabine—ADA—Metabolism—PPP1R3C—epilepsy syndrome	0.000167	0.000535	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GBE1—epilepsy syndrome	0.000167	0.000535	CbGpPWpGaD
Nelarabine—Headache—Levetiracetam—epilepsy syndrome	0.000167	0.000281	CcSEcCtD
Nelarabine—Malnutrition—Gabapentin—epilepsy syndrome	0.000166	0.000281	CcSEcCtD
Nelarabine—DCK—Metabolism—ATIC—epilepsy syndrome	0.000166	0.000531	CbGpPWpGaD
Nelarabine—DCK—Metabolism—UPB1—epilepsy syndrome	0.000166	0.000531	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NEU1—epilepsy syndrome	0.000166	0.000531	CbGpPWpGaD
Nelarabine—Dizziness—Vigabatrin—epilepsy syndrome	0.000166	0.000279	CcSEcCtD
Nelarabine—Confusional state—Valproic Acid—epilepsy syndrome	0.000165	0.000279	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ABCB1—epilepsy syndrome	0.000165	0.000529	CbGpPWpGaD
Nelarabine—Oedema—Valproic Acid—epilepsy syndrome	0.000164	0.000277	CcSEcCtD
Nelarabine—Nausea—Propofol—epilepsy syndrome	0.000164	0.000276	CcSEcCtD
Nelarabine—Vomiting—Fosphenytoin—epilepsy syndrome	0.000163	0.000276	CcSEcCtD
Nelarabine—Diarrhoea—Felbamate—epilepsy syndrome	0.000163	0.000276	CcSEcCtD
Nelarabine—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000163	0.000275	CcSEcCtD
Nelarabine—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000163	0.000275	CcSEcCtD
Nelarabine—Dysgeusia—Gabapentin—epilepsy syndrome	0.000163	0.000275	CcSEcCtD
Nelarabine—Dizziness—Diazepam—epilepsy syndrome	0.000163	0.000275	CcSEcCtD
Nelarabine—Infection—Valproic Acid—epilepsy syndrome	0.000163	0.000275	CcSEcCtD
Nelarabine—Leukopenia—Pregabalin—epilepsy syndrome	0.000163	0.000274	CcSEcCtD
Nelarabine—Asthenia—Clonazepam—epilepsy syndrome	0.000162	0.000273	CcSEcCtD
Nelarabine—Back pain—Gabapentin—epilepsy syndrome	0.000161	0.000272	CcSEcCtD
Nelarabine—Headache—Fosphenytoin—epilepsy syndrome	0.000161	0.000272	CcSEcCtD
Nelarabine—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000161	0.000271	CcSEcCtD
Nelarabine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	0.00016	0.000271	CcSEcCtD
Nelarabine—Asthenia—Phenytoin—epilepsy syndrome	0.00016	0.000271	CcSEcCtD
Nelarabine—Nausea—Midazolam—epilepsy syndrome	0.00016	0.00027	CcSEcCtD
Nelarabine—Hypoaesthesia—Topiramate—epilepsy syndrome	0.00016	0.00027	CcSEcCtD
Nelarabine—Diarrhoea—Zonisamide—epilepsy syndrome	0.00016	0.00027	CcSEcCtD
Nelarabine—DCK—Metabolism—HSD17B4—epilepsy syndrome	0.00016	0.000512	CbGpPWpGaD
Nelarabine—Loss of consciousness—Pregabalin—epilepsy syndrome	0.00016	0.000269	CcSEcCtD
Nelarabine—Asthenia—Oxcarbazepine—epilepsy syndrome	0.00016	0.000269	CcSEcCtD
Nelarabine—Vomiting—Vigabatrin—epilepsy syndrome	0.000159	0.000269	CcSEcCtD
Nelarabine—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000159	0.000268	CcSEcCtD
Nelarabine—Oedema peripheral—Topiramate—epilepsy syndrome	0.000159	0.000267	CcSEcCtD
Nelarabine—Cough—Pregabalin—epilepsy syndrome	0.000158	0.000267	CcSEcCtD
Nelarabine—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000158	0.000267	CcSEcCtD
Nelarabine—Nausea—Levetiracetam—epilepsy syndrome	0.000158	0.000267	CcSEcCtD
Nelarabine—Dizziness—Felbamate—epilepsy syndrome	0.000158	0.000266	CcSEcCtD
Nelarabine—Urethral disorder—Topiramate—epilepsy syndrome	0.000158	0.000266	CcSEcCtD
Nelarabine—Convulsion—Pregabalin—epilepsy syndrome	0.000157	0.000265	CcSEcCtD
Nelarabine—ADA—Metabolism—ASAH1—epilepsy syndrome	0.000157	0.000503	CbGpPWpGaD
Nelarabine—Vision blurred—Gabapentin—epilepsy syndrome	0.000157	0.000265	CcSEcCtD
Nelarabine—Headache—Vigabatrin—epilepsy syndrome	0.000157	0.000265	CcSEcCtD
Nelarabine—Vomiting—Diazepam—epilepsy syndrome	0.000157	0.000265	CcSEcCtD
Nelarabine—Anorexia—Valproic Acid—epilepsy syndrome	0.000156	0.000264	CcSEcCtD
Nelarabine—Tremor—Gabapentin—epilepsy syndrome	0.000156	0.000263	CcSEcCtD
Nelarabine—Myalgia—Pregabalin—epilepsy syndrome	0.000155	0.000261	CcSEcCtD
Nelarabine—Arthralgia—Pregabalin—epilepsy syndrome	0.000155	0.000261	CcSEcCtD
Nelarabine—Chest pain—Pregabalin—epilepsy syndrome	0.000155	0.000261	CcSEcCtD
Nelarabine—Dizziness—Zonisamide—epilepsy syndrome	0.000154	0.000261	CcSEcCtD
Nelarabine—Headache—Diazepam—epilepsy syndrome	0.000154	0.000261	CcSEcCtD
Nelarabine—DCK—Metabolism—PPP1R3C—epilepsy syndrome	0.000154	0.000494	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GBE1—epilepsy syndrome	0.000154	0.000494	CbGpPWpGaD
Nelarabine—Diarrhoea—Clonazepam—epilepsy syndrome	0.000154	0.00026	CcSEcCtD
Nelarabine—Anaemia—Gabapentin—epilepsy syndrome	0.000154	0.00026	CcSEcCtD
Nelarabine—DGUOK—Metabolism—GPX1—epilepsy syndrome	0.000154	0.000492	CbGpPWpGaD
Nelarabine—Hypotension—Valproic Acid—epilepsy syndrome	0.000153	0.000258	CcSEcCtD
Nelarabine—Asthenia—Carbamazepine—epilepsy syndrome	0.000153	0.000258	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	0.000153	0.00049	CbGpPWpGaD
Nelarabine—Diarrhoea—Phenytoin—epilepsy syndrome	0.000153	0.000258	CcSEcCtD
Nelarabine—ADA—Metabolism—STXBP1—epilepsy syndrome	0.000153	0.00049	CbGpPWpGaD
Nelarabine—Nausea—Fosphenytoin—epilepsy syndrome	0.000153	0.000258	CcSEcCtD
Nelarabine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000152	0.000257	CcSEcCtD
Nelarabine—Vomiting—Felbamate—epilepsy syndrome	0.000152	0.000256	CcSEcCtD
Nelarabine—Eye disorder—Topiramate—epilepsy syndrome	0.00015	0.000254	CcSEcCtD
Nelarabine—Headache—Felbamate—epilepsy syndrome	0.000149	0.000252	CcSEcCtD
Nelarabine—Confusional state—Pregabalin—epilepsy syndrome	0.000149	0.000252	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000149	0.000252	CcSEcCtD
Nelarabine—Cardiac disorder—Topiramate—epilepsy syndrome	0.000149	0.000252	CcSEcCtD
Nelarabine—Leukopenia—Gabapentin—epilepsy syndrome	0.000149	0.000251	CcSEcCtD
Nelarabine—ADA—Metabolism—ALAD—epilepsy syndrome	0.000149	0.000477	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NT5E—epilepsy syndrome	0.000149	0.000477	CbGpPWpGaD
Nelarabine—Dizziness—Clonazepam—epilepsy syndrome	0.000149	0.000251	CcSEcCtD
Nelarabine—Nausea—Vigabatrin—epilepsy syndrome	0.000149	0.000251	CcSEcCtD
Nelarabine—Vomiting—Zonisamide—epilepsy syndrome	0.000149	0.000251	CcSEcCtD
Nelarabine—Insomnia—Valproic Acid—epilepsy syndrome	0.000148	0.00025	CcSEcCtD
Nelarabine—Oedema—Pregabalin—epilepsy syndrome	0.000148	0.00025	CcSEcCtD
Nelarabine—Asthenia—Lamotrigine—epilepsy syndrome	0.000148	0.00025	CcSEcCtD
Nelarabine—Dizziness—Phenytoin—epilepsy syndrome	0.000148	0.00025	CcSEcCtD
Nelarabine—Infection—Pregabalin—epilepsy syndrome	0.000147	0.000248	CcSEcCtD
Nelarabine—Paraesthesia—Valproic Acid—epilepsy syndrome	0.000147	0.000248	CcSEcCtD
Nelarabine—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000147	0.000248	CcSEcCtD
Nelarabine—Nausea—Diazepam—epilepsy syndrome	0.000146	0.000247	CcSEcCtD
Nelarabine—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000146	0.000247	CcSEcCtD
Nelarabine—Headache—Zonisamide—epilepsy syndrome	0.000146	0.000247	CcSEcCtD
Nelarabine—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000146	0.000247	CcSEcCtD
Nelarabine—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000146	0.000246	CcSEcCtD
Nelarabine—Angiopathy—Topiramate—epilepsy syndrome	0.000146	0.000246	CcSEcCtD
Nelarabine—Somnolence—Valproic Acid—epilepsy syndrome	0.000146	0.000246	CcSEcCtD
Nelarabine—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000145	0.000245	CcSEcCtD
Nelarabine—Cough—Gabapentin—epilepsy syndrome	0.000145	0.000245	CcSEcCtD
Nelarabine—Thrombocytopenia—Pregabalin—epilepsy syndrome	0.000145	0.000245	CcSEcCtD
Nelarabine—DCK—Metabolism—ASAH1—epilepsy syndrome	0.000145	0.000465	CbGpPWpGaD
Nelarabine—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000145	0.000245	CcSEcCtD
Nelarabine—Chills—Topiramate—epilepsy syndrome	0.000144	0.000244	CcSEcCtD
Nelarabine—Convulsion—Gabapentin—epilepsy syndrome	0.000144	0.000243	CcSEcCtD
Nelarabine—Vomiting—Clonazepam—epilepsy syndrome	0.000143	0.000242	CcSEcCtD
Nelarabine—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000142	0.00024	CcSEcCtD
Nelarabine—Vomiting—Phenytoin—epilepsy syndrome	0.000142	0.00024	CcSEcCtD
Nelarabine—ADA—Metabolism—CACNA1A—epilepsy syndrome	0.000142	0.000455	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALDH7A1—epilepsy syndrome	0.000142	0.000455	CbGpPWpGaD
Nelarabine—Chest pain—Gabapentin—epilepsy syndrome	0.000142	0.000239	CcSEcCtD
Nelarabine—Arthralgia—Gabapentin—epilepsy syndrome	0.000142	0.000239	CcSEcCtD
Nelarabine—Myalgia—Gabapentin—epilepsy syndrome	0.000142	0.000239	CcSEcCtD
Nelarabine—Nausea—Felbamate—epilepsy syndrome	0.000142	0.000239	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000142	0.000239	CcSEcCtD
Nelarabine—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000141	0.000239	CcSEcCtD
Nelarabine—Fatigue—Valproic Acid—epilepsy syndrome	0.000141	0.000238	CcSEcCtD
Nelarabine—Anorexia—Pregabalin—epilepsy syndrome	0.000141	0.000238	CcSEcCtD
Nelarabine—Dizziness—Carbamazepine—epilepsy syndrome	0.000141	0.000238	CcSEcCtD
Nelarabine—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000141	0.000238	CcSEcCtD
Nelarabine—DCK—Metabolism—STXBP1—epilepsy syndrome	0.000141	0.000452	CbGpPWpGaD
Nelarabine—Headache—Clonazepam—epilepsy syndrome	0.000141	0.000238	CcSEcCtD
Nelarabine—Mental disorder—Topiramate—epilepsy syndrome	0.000141	0.000238	CcSEcCtD
Nelarabine—Constipation—Valproic Acid—epilepsy syndrome	0.00014	0.000237	CcSEcCtD
Nelarabine—Pain—Valproic Acid—epilepsy syndrome	0.00014	0.000237	CcSEcCtD
Nelarabine—Headache—Phenytoin—epilepsy syndrome	0.00014	0.000236	CcSEcCtD
Nelarabine—Malnutrition—Topiramate—epilepsy syndrome	0.00014	0.000236	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—JUN—epilepsy syndrome	0.00014	0.000447	CbGpPWpGaD
Nelarabine—Headache—Oxcarbazepine—epilepsy syndrome	0.000139	0.000235	CcSEcCtD
Nelarabine—ADA—Metabolism—ST3GAL3—epilepsy syndrome	0.000139	0.000446	CbGpPWpGaD
Nelarabine—Nausea—Zonisamide—epilepsy syndrome	0.000139	0.000234	CcSEcCtD
Nelarabine—Hypotension—Pregabalin—epilepsy syndrome	0.000138	0.000234	CcSEcCtD
Nelarabine—DCK—Metabolism—NT5E—epilepsy syndrome	0.000138	0.00044	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALAD—epilepsy syndrome	0.000138	0.00044	CbGpPWpGaD
Nelarabine—Dysgeusia—Topiramate—epilepsy syndrome	0.000137	0.000231	CcSEcCtD
Nelarabine—Confusional state—Gabapentin—epilepsy syndrome	0.000137	0.000231	CcSEcCtD
Nelarabine—Dizziness—Lamotrigine—epilepsy syndrome	0.000136	0.00023	CcSEcCtD
Nelarabine—ADA—Metabolism—ADSL—epilepsy syndrome	0.000136	0.000436	CbGpPWpGaD
Nelarabine—Oedema—Gabapentin—epilepsy syndrome	0.000136	0.000229	CcSEcCtD
Nelarabine—Vomiting—Carbamazepine—epilepsy syndrome	0.000136	0.000229	CcSEcCtD
Nelarabine—Back pain—Topiramate—epilepsy syndrome	0.000135	0.000229	CcSEcCtD
Nelarabine—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000135	0.000228	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000135	0.000228	CcSEcCtD
Nelarabine—Infection—Gabapentin—epilepsy syndrome	0.000135	0.000228	CcSEcCtD
Nelarabine—DGUOK—Metabolism—AGT—epilepsy syndrome	0.000135	0.000431	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000134	0.000226	CcSEcCtD
Nelarabine—Insomnia—Pregabalin—epilepsy syndrome	0.000134	0.000226	CcSEcCtD
Nelarabine—Nausea—Clonazepam—epilepsy syndrome	0.000134	0.000226	CcSEcCtD
Nelarabine—Headache—Carbamazepine—epilepsy syndrome	0.000134	0.000226	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	0.000134	0.000428	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GLUL—epilepsy syndrome	0.000134	0.000428	CbGpPWpGaD
Nelarabine—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000133	0.000225	CcSEcCtD
Nelarabine—Paraesthesia—Pregabalin—epilepsy syndrome	0.000133	0.000225	CcSEcCtD
Nelarabine—Thrombocytopenia—Gabapentin—epilepsy syndrome	0.000133	0.000225	CcSEcCtD
Nelarabine—Nausea—Phenytoin—epilepsy syndrome	0.000133	0.000224	CcSEcCtD
Nelarabine—Dyspnoea—Pregabalin—epilepsy syndrome	0.000132	0.000223	CcSEcCtD
Nelarabine—Nausea—Oxcarbazepine—epilepsy syndrome	0.000132	0.000223	CcSEcCtD
Nelarabine—Vision blurred—Topiramate—epilepsy syndrome	0.000132	0.000223	CcSEcCtD
Nelarabine—DGUOK—Metabolism—APOE—epilepsy syndrome	0.000132	0.000422	CbGpPWpGaD
Nelarabine—Somnolence—Pregabalin—epilepsy syndrome	0.000132	0.000222	CcSEcCtD
Nelarabine—Tremor—Topiramate—epilepsy syndrome	0.000131	0.000221	CcSEcCtD
Nelarabine—DCK—Metabolism—ALDH7A1—epilepsy syndrome	0.000131	0.00042	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CACNA1D—epilepsy syndrome	0.000131	0.00042	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CACNA1A—epilepsy syndrome	0.000131	0.00042	CbGpPWpGaD
Nelarabine—Vomiting—Lamotrigine—epilepsy syndrome	0.000131	0.000221	CcSEcCtD
Nelarabine—Abdominal pain—Valproic Acid—epilepsy syndrome	0.00013	0.000219	CcSEcCtD
Nelarabine—Body temperature increased—Valproic Acid—epilepsy syndrome	0.00013	0.000219	CcSEcCtD
Nelarabine—Anorexia—Gabapentin—epilepsy syndrome	0.00013	0.000219	CcSEcCtD
Nelarabine—Anaemia—Topiramate—epilepsy syndrome	0.000129	0.000218	CcSEcCtD
Nelarabine—Headache—Lamotrigine—epilepsy syndrome	0.000129	0.000218	CcSEcCtD
Nelarabine—Decreased appetite—Pregabalin—epilepsy syndrome	0.000129	0.000217	CcSEcCtD
Nelarabine—DCK—Metabolism—ST3GAL3—epilepsy syndrome	0.000128	0.000411	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000128	0.000216	CcSEcCtD
Nelarabine—Fatigue—Pregabalin—epilepsy syndrome	0.000128	0.000216	CcSEcCtD
Nelarabine—Hypotension—Gabapentin—epilepsy syndrome	0.000127	0.000214	CcSEcCtD
Nelarabine—Nausea—Carbamazepine—epilepsy syndrome	0.000127	0.000214	CcSEcCtD
Nelarabine—Pain—Pregabalin—epilepsy syndrome	0.000127	0.000214	CcSEcCtD
Nelarabine—Constipation—Pregabalin—epilepsy syndrome	0.000127	0.000214	CcSEcCtD
Nelarabine—DCK—Metabolism—ADSL—epilepsy syndrome	0.000126	0.000403	CbGpPWpGaD
Nelarabine—Leukopenia—Topiramate—epilepsy syndrome	0.000125	0.000212	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000124	0.000209	CcSEcCtD
Nelarabine—DCK—Metabolism—GLUL—epilepsy syndrome	0.000123	0.000395	CbGpPWpGaD
Nelarabine—Loss of consciousness—Topiramate—epilepsy syndrome	0.000123	0.000208	CcSEcCtD
Nelarabine—Insomnia—Gabapentin—epilepsy syndrome	0.000123	0.000207	CcSEcCtD
Nelarabine—ADA—Metabolism—TXNRD1—epilepsy syndrome	0.000123	0.000393	CbGpPWpGaD
Nelarabine—Nausea—Lamotrigine—epilepsy syndrome	0.000123	0.000207	CcSEcCtD
Nelarabine—Cough—Topiramate—epilepsy syndrome	0.000122	0.000206	CcSEcCtD
Nelarabine—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000122	0.000206	CcSEcCtD
Nelarabine—Paraesthesia—Gabapentin—epilepsy syndrome	0.000122	0.000206	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—H2AFX—epilepsy syndrome	0.000122	0.00039	CbGpPWpGaD
Nelarabine—Convulsion—Topiramate—epilepsy syndrome	0.000121	0.000205	CcSEcCtD
Nelarabine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000121	0.000204	CcSEcCtD
Nelarabine—Dyspnoea—Gabapentin—epilepsy syndrome	0.000121	0.000204	CcSEcCtD
Nelarabine—DCK—Metabolism—CACNA1D—epilepsy syndrome	0.000121	0.000388	CbGpPWpGaD
Nelarabine—Somnolence—Gabapentin—epilepsy syndrome	0.000121	0.000204	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	0.000121	0.000387	CbGpPWpGaD
Nelarabine—Myalgia—Topiramate—epilepsy syndrome	0.000119	0.000201	CcSEcCtD
Nelarabine—Chest pain—Topiramate—epilepsy syndrome	0.000119	0.000201	CcSEcCtD
Nelarabine—Arthralgia—Topiramate—epilepsy syndrome	0.000119	0.000201	CcSEcCtD
Nelarabine—ADA—Metabolism—AQP1—epilepsy syndrome	0.000119	0.000382	CbGpPWpGaD
Nelarabine—Decreased appetite—Gabapentin—epilepsy syndrome	0.000118	0.000199	CcSEcCtD
Nelarabine—Asthenia—Valproic Acid—epilepsy syndrome	0.000118	0.000198	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000117	0.000198	CcSEcCtD
Nelarabine—Fatigue—Gabapentin—epilepsy syndrome	0.000117	0.000198	CcSEcCtD
Nelarabine—Abdominal pain—Pregabalin—epilepsy syndrome	0.000117	0.000198	CcSEcCtD
Nelarabine—Body temperature increased—Pregabalin—epilepsy syndrome	0.000117	0.000198	CcSEcCtD
Nelarabine—Constipation—Gabapentin—epilepsy syndrome	0.000116	0.000196	CcSEcCtD
Nelarabine—Pain—Gabapentin—epilepsy syndrome	0.000116	0.000196	CcSEcCtD
Nelarabine—Confusional state—Topiramate—epilepsy syndrome	0.000115	0.000195	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	0.000115	0.000367	CbGpPWpGaD
Nelarabine—Oedema—Topiramate—epilepsy syndrome	0.000114	0.000193	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—APEX1—epilepsy syndrome	0.000114	0.000365	CbGpPWpGaD
Nelarabine—Infection—Topiramate—epilepsy syndrome	0.000114	0.000192	CcSEcCtD
Nelarabine—DGUOK—Metabolism—POMC—epilepsy syndrome	0.000113	0.000363	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TXNRD1—epilepsy syndrome	0.000113	0.000363	CbGpPWpGaD
Nelarabine—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000112	0.000189	CcSEcCtD
Nelarabine—Nervous system disorder—Topiramate—epilepsy syndrome	0.000112	0.000189	CcSEcCtD
Nelarabine—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000112	0.000189	CcSEcCtD
Nelarabine—Thrombocytopenia—Topiramate—epilepsy syndrome	0.000112	0.000189	CcSEcCtD
Nelarabine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000111	0.000188	CcSEcCtD
Nelarabine—DCK—Metabolism—AQP1—epilepsy syndrome	0.00011	0.000352	CbGpPWpGaD
Nelarabine—Anorexia—Topiramate—epilepsy syndrome	0.000109	0.000184	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	0.000109	0.000349	CbGpPWpGaD
Nelarabine—Dizziness—Valproic Acid—epilepsy syndrome	0.000108	0.000183	CcSEcCtD
Nelarabine—ADA—Metabolism—CHRM3—epilepsy syndrome	0.000108	0.000345	CbGpPWpGaD
Nelarabine—ADA—Metabolism—KCNJ11—epilepsy syndrome	0.000108	0.000345	CbGpPWpGaD
Nelarabine—Abdominal pain—Gabapentin—epilepsy syndrome	0.000107	0.000181	CcSEcCtD
Nelarabine—Body temperature increased—Gabapentin—epilepsy syndrome	0.000107	0.000181	CcSEcCtD
Nelarabine—Hypotension—Topiramate—epilepsy syndrome	0.000107	0.00018	CcSEcCtD
Nelarabine—Asthenia—Pregabalin—epilepsy syndrome	0.000106	0.000179	CcSEcCtD
Nelarabine—Vomiting—Valproic Acid—epilepsy syndrome	0.000104	0.000176	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000104	0.000176	CcSEcCtD
Nelarabine—Insomnia—Topiramate—epilepsy syndrome	0.000103	0.000174	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ALB—epilepsy syndrome	0.000103	0.000331	CbGpPWpGaD
Nelarabine—Headache—Valproic Acid—epilepsy syndrome	0.000103	0.000173	CcSEcCtD
Nelarabine—Paraesthesia—Topiramate—epilepsy syndrome	0.000103	0.000173	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—APEX1—epilepsy syndrome	0.000102	0.000327	CbGpPWpGaD
Nelarabine—Dyspnoea—Topiramate—epilepsy syndrome	0.000102	0.000172	CcSEcCtD
Nelarabine—Somnolence—Topiramate—epilepsy syndrome	0.000102	0.000172	CcSEcCtD
Nelarabine—Diarrhoea—Pregabalin—epilepsy syndrome	0.000101	0.000171	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	0.000101	0.000324	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CHRM3—epilepsy syndrome	9.94e-05	0.000318	CbGpPWpGaD
Nelarabine—DCK—Metabolism—KCNJ11—epilepsy syndrome	9.94e-05	0.000318	CbGpPWpGaD
Nelarabine—Decreased appetite—Topiramate—epilepsy syndrome	9.94e-05	0.000168	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	9.87e-05	0.000167	CcSEcCtD
Nelarabine—Fatigue—Topiramate—epilepsy syndrome	9.86e-05	0.000166	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	9.82e-05	0.000315	CbGpPWpGaD
Nelarabine—Dizziness—Pregabalin—epilepsy syndrome	9.8e-05	0.000165	CcSEcCtD
Nelarabine—Constipation—Topiramate—epilepsy syndrome	9.78e-05	0.000165	CcSEcCtD
Nelarabine—Pain—Topiramate—epilepsy syndrome	9.78e-05	0.000165	CcSEcCtD
Nelarabine—Asthenia—Gabapentin—epilepsy syndrome	9.75e-05	0.000165	CcSEcCtD
Nelarabine—Nausea—Valproic Acid—epilepsy syndrome	9.74e-05	0.000164	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PRKCB—epilepsy syndrome	9.71e-05	0.000311	CbGpPWpGaD
Nelarabine—Vomiting—Pregabalin—epilepsy syndrome	9.42e-05	0.000159	CcSEcCtD
Nelarabine—Feeling abnormal—Topiramate—epilepsy syndrome	9.42e-05	0.000159	CcSEcCtD
Nelarabine—Gastrointestinal pain—Topiramate—epilepsy syndrome	9.35e-05	0.000158	CcSEcCtD
Nelarabine—Diarrhoea—Gabapentin—epilepsy syndrome	9.3e-05	0.000157	CcSEcCtD
Nelarabine—Headache—Pregabalin—epilepsy syndrome	9.28e-05	0.000157	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—H2AFX—epilepsy syndrome	9.12e-05	0.000292	CbGpPWpGaD
Nelarabine—Abdominal pain—Topiramate—epilepsy syndrome	9.04e-05	0.000153	CcSEcCtD
Nelarabine—Body temperature increased—Topiramate—epilepsy syndrome	9.04e-05	0.000153	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PTGS2—epilepsy syndrome	9.04e-05	0.000289	CbGpPWpGaD
Nelarabine—Dizziness—Gabapentin—epilepsy syndrome	8.99e-05	0.000152	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	8.81e-05	0.000282	CbGpPWpGaD
Nelarabine—Nausea—Pregabalin—epilepsy syndrome	8.8e-05	0.000149	CcSEcCtD
Nelarabine—ADA—Metabolism—ABCG2—epilepsy syndrome	8.78e-05	0.000281	CbGpPWpGaD
Nelarabine—Vomiting—Gabapentin—epilepsy syndrome	8.64e-05	0.000146	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	8.58e-05	0.000275	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP2C19—epilepsy syndrome	8.56e-05	0.000274	CbGpPWpGaD
Nelarabine—Headache—Gabapentin—epilepsy syndrome	8.51e-05	0.000144	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP11A1—epilepsy syndrome	8.51e-05	0.000272	CbGpPWpGaD
Nelarabine—Asthenia—Topiramate—epilepsy syndrome	8.2e-05	0.000138	CcSEcCtD
Nelarabine—POLA1—Cell Cycle—H2AFX—epilepsy syndrome	8.15e-05	0.000261	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCG2—epilepsy syndrome	8.11e-05	0.00026	CbGpPWpGaD
Nelarabine—Nausea—Gabapentin—epilepsy syndrome	8.07e-05	0.000136	CcSEcCtD
Nelarabine—DCK—Metabolism—CYP2C19—epilepsy syndrome	7.9e-05	0.000253	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP11A1—epilepsy syndrome	7.85e-05	0.000251	CbGpPWpGaD
Nelarabine—Diarrhoea—Topiramate—epilepsy syndrome	7.82e-05	0.000132	CcSEcCtD
Nelarabine—ADA—Metabolism—CYP2D6—epilepsy syndrome	7.68e-05	0.000246	CbGpPWpGaD
Nelarabine—Dizziness—Topiramate—epilepsy syndrome	7.56e-05	0.000128	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	7.36e-05	0.000236	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ADRA2A—epilepsy syndrome	7.31e-05	0.000234	CbGpPWpGaD
Nelarabine—ADA—Metabolism—BCHE—epilepsy syndrome	7.28e-05	0.000233	CbGpPWpGaD
Nelarabine—Vomiting—Topiramate—epilepsy syndrome	7.27e-05	0.000123	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—PRKCB—epilepsy syndrome	7.26e-05	0.000232	CbGpPWpGaD
Nelarabine—Headache—Topiramate—epilepsy syndrome	7.16e-05	0.000121	CcSEcCtD
Nelarabine—DCK—Metabolism—CYP2D6—epilepsy syndrome	7.08e-05	0.000227	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC2A1—epilepsy syndrome	6.94e-05	0.000222	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PLCB1—epilepsy syndrome	6.87e-05	0.00022	CbGpPWpGaD
Nelarabine—ADA—Metabolism—TH—epilepsy syndrome	6.84e-05	0.000219	CbGpPWpGaD
Nelarabine—Nausea—Topiramate—epilepsy syndrome	6.79e-05	0.000115	CcSEcCtD
Nelarabine—DCK—Metabolism—ADRA2A—epilepsy syndrome	6.74e-05	0.000216	CbGpPWpGaD
Nelarabine—Adenosine triphosphate—ABCB1—epilepsy syndrome	6.73e-05	0.00407	CrCbGaD
Nelarabine—DCK—Metabolism—BCHE—epilepsy syndrome	6.72e-05	0.000215	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—ATM—epilepsy syndrome	6.63e-05	0.000212	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PRKCB—epilepsy syndrome	6.49e-05	0.000208	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC2A1—epilepsy syndrome	6.41e-05	0.000205	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PLCB1—epilepsy syndrome	6.34e-05	0.000203	CbGpPWpGaD
Nelarabine—DCK—Metabolism—TH—epilepsy syndrome	6.31e-05	0.000202	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HMOX1—epilepsy syndrome	5.71e-05	0.000183	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CAT—epilepsy syndrome	5.63e-05	0.00018	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ABCB1—epilepsy syndrome	5.48e-05	0.000176	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	5.48e-05	0.000175	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HMOX1—epilepsy syndrome	5.27e-05	0.000169	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CAT—epilepsy syndrome	5.2e-05	0.000167	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GPX1—epilepsy syndrome	5.1e-05	0.000163	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ABCB1—epilepsy syndrome	5.06e-05	0.000162	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GPX1—epilepsy syndrome	4.7e-05	0.000151	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKT1—epilepsy syndrome	4.54e-05	0.000145	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AGT—epilepsy syndrome	4.47e-05	0.000143	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOE—epilepsy syndrome	4.38e-05	0.00014	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AGT—epilepsy syndrome	4.12e-05	0.000132	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOE—epilepsy syndrome	4.04e-05	0.000129	CbGpPWpGaD
Nelarabine—ADA—Metabolism—POMC—epilepsy syndrome	3.76e-05	0.00012	CbGpPWpGaD
Nelarabine—DCK—Metabolism—POMC—epilepsy syndrome	3.47e-05	0.000111	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALB—epilepsy syndrome	3.43e-05	0.00011	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALB—epilepsy syndrome	3.16e-05	0.000101	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS2—epilepsy syndrome	3e-05	9.61e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS2—epilepsy syndrome	2.77e-05	8.87e-05	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKT1—epilepsy syndrome	1.51e-05	4.83e-05	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKT1—epilepsy syndrome	1.39e-05	4.46e-05	CbGpPWpGaD
